CATHERINE PENCE: Open Payments
NPI 1932667474 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,071 in 53 payments from 10 companies in 2025. Trend: 2023 $901 · 2024 $1,061 · 2025 $1,071
Food & beverage: $1,071
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $232 |
| AstraZeneca Pharmaceuticals LP | 11 | $193 |
| Exact Sciences Corporation | 7 | $184 |
| Lilly USA, LLC | 9 | $163 |
| Abbott Laboratories | 4 | $94 |
| Amgen Inc. | 5 | $80 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Edwards Lifesciences Corporation | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $14 |
Products named: Cologuard Collection Kit, FARXIGA, MOUNJARO, FREESTYLE LIBRE 3, AIRSUPRA, Rybelsus, Wegovy, OTEZLA.
Industry payments across TX — which companies pay providers there.
